Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01411813 · ClinicalTrials.gov registry record

Alprazolam and Eating Behavior in Anorexia Nervosa

A clinical trial of Anorexia Nervosa, sponsored by New York State Psychiatric Institute.

Completed
Registry status
19
Enrollment target
1
Study location

NCT01411813 is a study of Anorexia Nervosa that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 19 participants, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01411813, a study of Anorexia Nervosa, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
19 participants
Enrollment target
1
Study location

Study Summary

This study examines the role of anxiety in food intake among patients with AN by measuring caloric intake in a standardized, laboratory meal with alprazolam versus a placebo. Patients will participate in two test meal sessions, one after receiving alprazolam and one after receiving a placebo. Patients will be administered psychological measures of anxiety, mood, and eating behavior. Primary outcomes include caloric intake in a laboratory test meal and pre-meal anxiety levels.

Conditions Studied

Anorexia Nervosa

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2010-11
Est. Completion 2011-10

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01411813

The ClinicalTrials.gov registry entry for NCT01411813 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 0 interventions.

NCT01411813 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01411813 about?

NCT01411813 is a clinical study titled "Alprazolam and Eating Behavior in Anorexia Nervosa". This study examines the role of anxiety in food intake among patients with AN by measuring caloric intake in a standardized, laboratory meal with alprazolam versus a placebo. Patients will participate in two test meal sessions, one after receiving alprazolam and one after receiving a placebo. Patien...

What is the current status of trial NCT01411813?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2010-11. Estimated completion is 2011-10.

What conditions does trial NCT01411813 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

Who is sponsoring clinical trial NCT01411813?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01411813 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anorexia Nervosa

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.